Trends in outpatient anti‐arrhythmic prescriptions for atrial fibrillation and left atrial ablation in Australia: 1997–2016
- 5 December 2017
- journal article
- research article
- Published by Wiley in Internal Medicine Journal
- Vol. 48 (4) , 427-432
Abstract
Background: An important aspect of atrial fibrillation (AF) management is the decision whether to adopt a rate or rhythm control strategy. Options for the latter include oral anti‐arrhythmic drugs (AAD) or catheter ablation.Aim: To describe the trends in rhythm control for AF in Australia between 1997 and 2016.Methods: We conducted a retrospective study using prospectively collected data between 1997 and 2016 from the Pharmaceutical Benefit Scheme and Medicare Benefit Schedule websites, which, respectively, contain information pertaining to public AAD prescriptions and rebatable AF ablation procedures performed in Australia.Results: Sotalol and amiodarone remain the most commonly prescribed AAD in Australia, although their use is decreasing. Rates of catheter ablation for AF continue to rise annually with a 48‐fold increase from 71 to 3480 since 1997.Conclusion: A rhythm control strategy is frequently utilised for AF management in Australia. Consistent with international guidelines which advocate safety over efficacy when choosing a rhythm control strategy, the prescriptions of amiodarone have been consistently decreasing since 2002, whereas sotalol and flecainide prescriptions have largely increased, with a peak in 2015. Catheter ablation per capita has burgeoned 36‐fold.Keywords
This publication has 28 references indexed in Scilit:
- Trends in atrial fibrillation ablation: have we maximized the current paradigms?Journal of Interventional Cardiac Electrophysiology, 2012
- Antiarrhythmic use from 1991 to 2007: Insights from the Canadian Registry of Atrial Fibrillation (CARAF I and II)Heart Rhythm, 2010
- Valsartan for Prevention of Recurrent Atrial FibrillationNew England Journal of Medicine, 2009
- Increased Mortality after Dronedarone Therapy for Severe Heart FailureNew England Journal of Medicine, 2008
- Rhythm Control versus Rate Control for Atrial Fibrillation and Heart FailureNew England Journal of Medicine, 2008
- Overweight and obesity as risk factors for atrial fibrillation or flutter: The Danish Diet, Cancer, and Health StudyThe American Journal of Medicine, 2005
- Relationships Between Sinus Rhythm, Treatment, and Survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) StudyCirculation, 2004
- A Comparison of Rate Control and Rhythm Control in Patients with Recurrent Persistent Atrial FibrillationNew England Journal of Medicine, 2002
- A Comparison of Rate Control and Rhythm Control in Patients with Atrial FibrillationNew England Journal of Medicine, 2002
- Mortality and Morbidity in Patients Receiving Encainide, Flecainide, or PlaceboNew England Journal of Medicine, 1991